Novel suppressive function of transitional 2 B cells in experimental arthritis

被引:429
作者
Evans, Jamie G.
Chavez-Rueda, Karina A.
Eddaoudi, Ayad
Meyer-Bahlburg, Almut
Rawlings, David J.
Ehrenstein, Michael R.
Mauri, Claudia
机构
[1] UCL, Ctr Rheumatol Res, Dept Med, London, England
[2] Canc Res United Kingdom, London, England
[3] Univ Washington, Seattle, WA 98195 USA
[4] Childrens Hosp & Reg Med Ctr, Dept Pediat, Seattle, WA 98195 USA
[5] Childrens Hosp & Reg Med Ctr, Dept Immunol, Seattle, WA 98195 USA
基金
英国惠康基金;
关键词
D O I
10.4049/jimmunol.178.12.7868
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immune system contains natural regulatory cells important in the maintenance of tolerance. Although this suppressive function is usually attributed to CD4 regulatory T cells, recent reports have revealed an immunoregulatory role for IL-10-producing B cells in the context of several autoimmune diseases including collagen-induced arthritis. In the present study, we attribute this suppressive function to a B cell subset expressing high levels of CD21, CD23, and IgM, previously identified as transitional 2-marginal zone precursor (T2-MZP) B cells. T2-MZP B cells are present in the spleens of naive mice and increase during the remission phase of arthritis. Following adoptive transfer to immunized DBA/1 mice, T2-MZP B cells significantly prevented new disease and ameliorated established disease. The suppressive effect on arthritis was paralleled by an inhibition of Ag-specific T cell activation and a reduction in cells exhibiting Thl-type functional responses. We also provide evidence that this regulatory subset mediates its suppression through the secretion of suppressive cytokines and not by cell-to-cell contact. The ability to regulate an established immune response by T2-MZP B cells endows this subset of B cells with a striking and previously unrecognized immunoregulatory potential.
引用
收藏
页码:7868 / 7878
页数:11
相关论文
共 42 条
[1]   Alternative routes to maturity: branch points and pathways for generating follicular and marginal zone B cells [J].
Allman, D ;
Srivastava, B ;
Lindsley, RC .
IMMUNOLOGICAL REVIEWS, 2004, 197 :147-160
[2]   Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation [J].
Allman, D ;
Lindsley, RC ;
DeMuth, W ;
Rudd, K ;
Shinton, SA ;
Hardy, RR .
JOURNAL OF IMMUNOLOGY, 2001, 167 (12) :6834-6840
[3]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[4]   Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells [J].
Attanavanich, K ;
Kearney, JF .
JOURNAL OF IMMUNOLOGY, 2004, 172 (02) :803-811
[5]   Nuclear factor κB is required for the development of marginal zone B lymphocytes [J].
Cariappa, A ;
Liou, HC ;
Horwitz, BH ;
Pillai, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (08) :1175-1182
[6]   The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21 [J].
Cariappa, A ;
Tang, M ;
Parng, C ;
Nebelitskiy, E ;
Carroll, M ;
Georgopoulos, K ;
Pillai, S .
IMMUNITY, 2001, 14 (05) :603-615
[7]   Peripheral development of B cells in mouse and man [J].
Carsetti, R ;
Rosado, MM ;
Wardemann, H .
IMMUNOLOGICAL REVIEWS, 2004, 197 :179-191
[8]   Incomplete activation of CD4 T cells by antigen-presenting transitional immature B cells: Implications for peripheral B and T cell responsiveness [J].
Chung, JB ;
Wells, AD ;
Adler, S ;
Jacob, A ;
Turka, LA ;
Monroe, JG .
JOURNAL OF IMMUNOLOGY, 2003, 171 (04) :1758-1767
[9]   CD23 defines two distinct subsets of immature B cells which differ in their responses to T cell help signals [J].
Chung, JB ;
Sater, RA ;
Fields, ML ;
Erikson, J ;
Monroe, JG .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (02) :157-166
[10]   B cell developmental requirement for the Gαi2 gene [J].
Dalwadi, H ;
Wei, B ;
Schrage, M ;
Su, TT ;
Rawlings, DJ ;
Braun, J .
JOURNAL OF IMMUNOLOGY, 2003, 170 (04) :1707-1715